Brean Murray Initiating Coverage On Onyx Pharmaceuticals, Inc. (NASDAQ)

by Jonathan Chen, Benzinga Staff Writer
August 31, 2011 7:47 AM | 12 seconds read |
Brean Murray Carret & Co. is out with a research report on Onyx Pharmaceuticals, Inc. ONXX and it is initiating coverage with a Hold rating. Shares of ONXX closed at $33.69 yesterday, down 1 cent.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Analyst ColorInitiationAnalyst RatingsBiotechnologyBrean Murray Carret & Co.Health Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!